Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Sareum Share Price
  4. Sareum Share Regulatory News
  5. Second Price Monitoring Extn

Pin to quick picksSareum Regulatory News (SAR)

Sareum Information

Share Price Information for Sareum (SAR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    1.00 (4.65%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £31.18m
SAR Live PriceLast checked at - London Stock Exchange

Intraday Sareum Share Chart

Second Price Monitoring Extn

24 Jun 2021 14:05

RNS Number : 0424D
Sareum Holdings PLC
24 June 2021
 

Second Price Monitoring Extension

*Please note that due to low readership, RNS is considering the possible decommissioning of Price Monitoring Extension announcements. We would welcome any feedback you may have about these announcements; in particular, whether you find them valuable and would like to continue receiving them via RNS. Please send feedback to rns@lseg.com *.

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMGZGZVFDKGMZM
12345678910
Date   Source Headline
8th Oct 20207:00 amRNSUS Patent Allowance: SDC-1802 TYK2/JAK1 Inhibitor
12th Aug 20207:00 amRNSDetails of Investor Presentation
11th Aug 20207:00 amRNSTrading Statement
29th Jul 20202:05 pmRNSSecond Price Monitoring Extn
29th Jul 20202:00 pmRNSPrice Monitoring Extension
24th Jul 20207:00 amRNSResearch Update
1st Jul 20207:00 amRNSUpdate on Deferred Salaries and Issue of Equity
3rd Jun 202011:06 amRNSSecond Price Monitoring Extn
3rd Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSSuccessful Fundraising
2nd Jun 20204:31 pmRNSPrimaryBid.com Offer
2nd Jun 20204:30 pmRNSPlacing to raise £718,500
27th May 20207:00 amRNSSareum to Present at BIO Digital 2020
1st May 20207:00 amRNSBioTrinity Presentation Available Online
28th Apr 20207:00 amRNSCompany Presentation at BioTrinity
20th Apr 202011:00 amRNSPrice Monitoring Extension
17th Apr 202011:05 amRNSSecond Price Monitoring Extn
17th Apr 202011:00 amRNSPrice Monitoring Extension
14th Apr 202011:06 amRNSSecond Price Monitoring Extn
14th Apr 202011:01 amRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSHalf-year Report
26th Mar 20207:00 amRNSGlobal Licensing of FL3+Aurora Programme
12th Mar 20207:00 amRNSPublication: new SRA737 combinations in cancer
17th Dec 20191:36 pmRNSResult of AGM
17th Dec 20197:00 amRNSAGM Statement
20th Nov 20197:00 amRNSNotice of AGM
5th Nov 201910:56 amRNSSareum notes Sierra Oncology Q3 2019 results
30th Oct 20197:00 amRNSResearch Update - SDC-1802 anti-cancer poster
17th Oct 20197:00 amRNSResearch Update - AACR-NCI-EORTC abstract
15th Oct 20197:00 amRNSFinal Results
7th Oct 20197:00 amRNSNotice of Full Year Results
27th Sep 20197:00 amRNSResearch Update - TYK2/JAK1 cancer programme
27th Aug 20197:00 amRNSTrading Statement
16th Aug 20197:00 amRNSChange of Adviser
8th Aug 20192:17 pmRNSSareum notes Sierra Q2 results
29th Jul 20194:29 pmRNSAdditional disclosure concerning Michael Owen
28th Jun 20197:00 amRNSAdditional Funds Raised
27th Jun 20191:50 pmRNSSierra seeks strategic options for SRA737
26th Jun 20197:00 amRNSSuccessful Fundraising
25th Jun 20194:31 pmRNSPrimaryBid.com Offer
25th Jun 20194:30 pmRNSPlacing to progress TYK2/JAK1 programmes
13th Jun 20197:00 amRNSPortfolio Update
3rd Jun 20194:00 pmRNSKey takeaways from SRA737 webcast at ASCO
3rd Jun 201911:05 amRNSSecond Price Monitoring Extn
3rd Jun 201911:00 amRNSPrice Monitoring Extension
3rd Jun 20197:00 amRNSPositive SRA737 data presented at ASCO
16th May 20197:00 amRNSASCO abstracts for SRA737 published
8th May 201912:41 pmRNSSareum notes Sierra Oncology Q1 2019 Results
30th Apr 20197:00 amRNSSareum to Present at BioTrinity 2019 in London
23rd Apr 20197:00 amRNSSRA737 Phase I/IIa data to be presented at ASCO
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SAR
Sareum
LSE
4.65%
CDI
CDI.L
LSE
0.00%
MXF
Medicx Fund
LSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-20.00%
ITM
Itm Power
LSE
-4.99%
RRR
Red Rock Resources
LSE
15.91%
MKA
Mkango Resources
LSE
-4.52%
QHE
Quantum Helium
LSE
-6.54%